🇺🇸 FDA
Pipeline program

PF-06651600 Induction Dose

B7981015

Phase 3 small_molecule completed

Quick answer

PF-06651600 Induction Dose for Alopecia Areata is a Phase 3 program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).

Program details

Company
Pfizer
Indication
Alopecia Areata
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials